Phenomenology and psychiatric correlates of pseudocataplexy.

functional neurological disorder narcolepsy type 1 pseudocataplexy psychiatric profile

Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
08 Sep 2023
Historique:
received: 07 06 2023
medline: 8 9 2023
pubmed: 8 9 2023
entrez: 8 9 2023
Statut: aheadofprint

Résumé

Pseudocataplexy is a rare functional neurological disorder that mimics cataplexy, pathognomonic for narcolepsy type 1 (NT1). We describe the psychiatric comorbidity and personality traits of patients with pseudocataplexy versus NT1 cases. The case-control observational study enrolled consecutive patients with pseudocataplexy and a control group of age-matched consecutive NT1 patients. The diagnostic work-up included a structured interview, 48-hour polysomnography, multiple sleep latency test, cataplexy provoking test, and hypocretin-1 measurement in cerebrospinal fluid.All participants were administered Beck Depression Inventory, State-Trait Anxiety Inventory, Patient Health Questionnaire-15 (PHQ-15), Personality Inventory for DSM-5 brief form, and quality of life (QoL) measurement by 36-item Short Form health survey (SF-36). Fifteen patients with pseudocataplexy and 30 with NT1 were included. Despite the suspicion of possible cataplexy, none of the pseudocataplexy participants fulfilled international diagnostic criteria for NT1. Pseudocataplexy patients presented higher rates of moderate state anxiety (40% vs. 10%, p=0.018), medium level of somatic symptoms, defined by PHQ-15 score >10 (66.7% vs. 16.7%, p=0.003), and a trend towards moderate-to-severe depressive symptoms (33.3% vs. 10%, p=0.054) compared to NT1. No significant differences in personality traits emerged. Pseudocataplexy patients had worse QoL profile in almost all SF-36 domains including physical (mean±SD: 37.7±9.88 vs. 51.13±7.81, p<0.001) and mental (mean±SD: 33.36±12.69 vs.42.76±11.34, p=0.02) summary scores. Patients with pseudocataplexy present more severe psychiatric symptoms and a lower QoL profile in comparison with patients with NT1. The severe somatoform and affection impairment in pseudocataplexy may explain the poorer QoL and should require a tailored therapeutic approach.

Identifiants

pubmed: 37682005
pii: 7264149
doi: 10.1093/sleep/zsad234
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Sleep Research Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Marco Menchetti (M)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Department of Mental Health and Substance Abuse, Local Health Trust of Bologna, Bologna Italy.

Francesco Biscarini (F)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Giombattista Sallemi (G)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Elena Antelmi (E)

DIMI Department of engineering and medicine of innovation, University of Verona, Verona, Italy.

Christian Franceschini (C)

Department of Medicine and Surgery, University of Parma, Parma, Italy.

Stefano Vandi (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Giulia Neccia (G)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Valentina Baldini (V)

Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Giuseppe Plazzi (G)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.

Fabio Pizza (F)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Classifications MeSH